Zanthoxylum nitidum shows multi-target anti-HCC mechanisms via network pharmacology
The study identifies key genes and pathways involved in the anti-HCC mechanisms of Zanthoxylum nitidum, highlighting its potential clinical use.
Asset / Drug
Drug and asset intelligence for Zanthoxylum with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.